Truth or Consequences from the NoseBleed Seats

IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP.  If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org 

Copyright 2020 © by National Association of Pediatric Nurse Practitioners (NAPNAP) 

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.5 NAPNAP contact hour, of which 0 contains pharmacology content

Keywords: nose bleed, bleeding, epistaxis, hematology

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

  • Analyze the causes of epistaxis and discuss when further investigation is needed to identify possible bleeding disorder or to make specialty referrals
  • Discuss the treatment options for common nose bleeds as well as individual treatment options 
  • Understand the consequences of frequent heavy nose bleeding and identify the management and follow up needed for these children
Course summary
Available credit: 
  • 0.50 Contact hours
Course opens: 
06/23/2020
Course expires: 
07/31/2021
Cost:
$10.00
Rating: 
0

Terea Giannetta, RN, DNP, CPNP, FAANP Valley Children’s Hospital, Hematology 

 

Disclosure. No disclosures to report.

 

Correspondence: email tgiannetta@valleychildrens.org

Available Credit

  • 0.50 Contact hours

Price

Cost:
$10.00
Please login or register to take this course.